Non-lysosomal cycling pathway for atrial natriuretic peptide activated by protein kinase C in human NPE cells.
Atrial natriuretic peptide (ANP) stimulates aqueous humor formation in primates, but the membrane-bound receptors which mediate this effect have not been well studied in the eye. Endocytosis of [125I]ANP bound to natriuretic peptide C receptors was characterized in fetal human nonpigmented ciliary epithelial (NPE) cells. [125I]ANP which bound to cells at 4 degreesC was detected in the cell interior after a temperature shift to 37 degreesC. Appearance of ligand within the cell peaked at 5 min, and then declined towards zero over 20 min. The endocytosis inhibitor phenylarsine oxide blocked the appearance of internalized ligand, whereas the lysosomotropic drug chloroquine had no effect on internalization but blocked subsequent loss of internalized ligand. Chloroquine also blocked the accumulation of degraded ligand in the extracellular medium. Treatment with phorbol 12-myristate, 13-acetate accelerated the loss of internalized ligand from cells and increased the accumulation of ligand in the extracellular medium. Ligand in the medium was also increased by dioctanoylglycerol but not by 4alpha phorbol didecanoate, an isomer which does not activate protein kinase C. The protein kinase inhibitors staurosporine and bisindolylymaleimide blocked the increase in ligand. Phorbol ester-stimulated loss of internalized ligand occurred in the presence of chloroquine. TCA precipitation of ligand in the extracellular medium showed that both degraded and undegraded [125I]ANP were present. However, in the presence of chloroquine only, undegraded ANP was detected in the medium, and phorbol esters stimulated its rate of appearance by approximately 2 fold. A similar stimulation occurred when cells containing internalized ligand, but stripped of membrane-bound ligand, were exposed to phorbol esters. The data suggest that ANP bound to natriuretic peptide C receptors on NPE cells is endocytosed, and that protein kinase C activates a non-lysosomal pathway for ANP retroendocytosis in these cells.
Lehman
N L
NL
Cellular Pharmacology Laboratory, Department of Ophthalmology, University of California, Box 0730, San Francisco, CA, 94143, USA.
Chang
A T
AT
Crook
R B
RB
D001152:Arsenicals / Q000494:pharmacology; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D018929:Cell Culture Techniques; D002738:Chloroquine / Q000494:pharmacology; D002924:Ciliary Body / Q000378:metabolism*; D004705:Endocytosis / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008247:Lysosomes / Q000502:physiology; D010857:Pigment Epithelium of Eye / Q000378:metabolism*; D011493:Protein Kinase C / Q000502:physiology*; D013696:Temperature; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D001152:Arsenicals; D004791:Enzyme Inhibitors; C029341:oxophenylarsine; D009320:Atrial Natriuretic Factor; D002738:Chloroquine; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate